In a regulatory filing, Core Scientific (CORZ) director Jordan Levy disclosed the purchase of 62,500 common shares of the company on March 6 at a price of $8.0081 per share.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ: